Biological Sample Handling Market by Product Type (Consumables, Instruments, Reagents And Kits), End User (Academic And Research Institutes, Biopharmaceutical Companies, Contract Research Organizations), Application, Sample Type, Workflow - Global Forecas
Description
The Biological Sample Handling Market was valued at USD 19.85 billion in 2024 and is projected to grow to USD 21.19 billion in 2025, with a CAGR of 6.62%, reaching USD 33.16 billion by 2032.
Revolutionizing Sample Integrity Through Strategic Biological Specimen Management to Elevate Research Quality and Patient Outcomes Across Global Markets
Biological sample handling stands at the heart of both clinical diagnostics and groundbreaking research initiatives, where specimen integrity directly influences the accuracy of analytical outcomes. The critical imperative to maintain sample viability from collection through analysis has never been more pronounced, as laboratories contend with increasingly stringent regulatory expectations and the imperative to drive operational efficiency. From academic institutions to diagnostic laboratories, the ability to manage specimens under precise temperature, contamination control, and traceability conditions underpins successful outcomes and fosters trust in results.
As the complexity of life science research expands, stakeholders must navigate a fragmented ecosystem of consumables, instruments, reagents, and software platforms designed to safeguard specimen quality. The demand for seamless integration across each phase of sample workflow has catalyzed a wave of innovation in automated systems, digital monitoring solutions, and advanced reagent formulations. By examining the foundational elements of specimen management, this report sets the stage for an in-depth exploration of technological advancements, regulatory influences, and market dynamics, equipping decision makers with the insights necessary to anticipate emerging challenges and capitalize on transformative opportunities.
Navigating Disruptive Technological and Operational Shifts Driving Next Generation Sample Handling Solutions in Life Sciences and Diagnostics Sectors
The landscape of biological sample handling is undergoing a rapid metamorphosis driven by the convergence of advanced automation, digitalization, and data analytics. Cutting-edge robotic pipetting solutions, integrated with real-time monitoring sensors, are redefining laboratory throughput and reducing human error. Concurrently, the rise of cloud-based laboratory informatics platforms enables seamless data capture, secure traceability, and remote oversight, revolutionizing how teams collaborate across geographic boundaries.
Moreover, the integration of artificial intelligence and machine learning tools is empowering predictive maintenance of critical equipment, early detection of deviations in sample storage conditions, and optimization of workflow processes. These transformative shifts not only enhance operational resilience but also facilitate compliance with evolving regulatory frameworks. In parallel, sustainability imperatives are driving the development of eco-friendly consumables and energy-efficient cold chain solutions. Altogether, this fusion of technological, environmental, and compliance-driven advances signals a new era in sample handling-one defined by precision, connectivity, and agility.
Evaluating the Broad Repercussions of New United States Tariff Regulations in 2025 on the Complex Ecosystem of Biological Sample Handling Supplies and Services
The introduction of revised tariff measures by the United States in 2025 has exerted multifaceted pressure across the biological sample handling supply chain. Elevated duties on imported reagents, consumables, and specialized instruments have prompted procurement teams to reevaluate sourcing strategies and negotiate new partnerships. In response to cost escalations, several stakeholders have pursued localized manufacturing collaborations, thereby mitigating exposure to volatile trade policies and reducing lead times for critical supplies.
Transitioning from traditional global sourcing models, companies are investing in regional distribution hubs and forging alliances with domestic producers to preserve margin integrity and ensure uninterrupted access to essential sample processing materials. Simultaneously, end users have been compelled to recalibrate budgeting forecasts, prioritizing products that deliver heightened durability and extended shelf life to offset incremental expenses. As organizations adapt to this evolving tariff landscape, the emphasis on supply chain transparency, compliance management, and strategic inventory buffering will continue to shape the competitive dynamics of the sample handling market.
Gaining Deep Insights into Product, End User, Application, Sample Type, and Workflow Segmentation to Optimize Biological Sample Handling Strategies
Deep segmentation analysis uncovers unique insights across product categories, end user profiles, application areas, sample types, and workflow stages. Within the spectrum of product types, the market extends from fundamental consumables and sophisticated instruments to specialized reagents and kits and comprehensive software and services. Instruments such as automated pipetting systems, temperature controlled centrifuges, and vortex mixers are gaining momentum, while reagents and kits comprised of antibodies, buffers and solutions, enzymes, and labeling and detection reagents underpin critical assay performance.
Turning to end users, the needs of academic and research institutes, biopharmaceutical companies, contract research organizations, diagnostic laboratories, and hospitals diverge based on throughput requirements and regulatory mandates. Diagnostic laboratories, encompassing clinical chemistry, hematology, microbiology, and molecular diagnostics, remain particularly sensitive to throughput and quality control imperatives. Application segmentation highlights the prominence of diagnostics, drug discovery and development, genomics, and proteomics, with laboratory diagnostics and point of care modalities transforming healthcare delivery.
Sample type considerations reveal distinct protocols for blood, cells, tissue, and urine, each demanding tailored handling and preservation solutions. Furthermore, the sample handling workflow traverses analysis, collection, processing, storage, and transport, where each phase presents specific performance benchmarks. By synthesizing these segmentation dimensions, stakeholders can align product portfolios with evolving user requirements and optimize channel strategies to unlock sustained value.
Uncovering Regional Dynamics Shaping Biological Sample Handling Markets in the Americas, Europe Middle East Africa, and Asia Pacific Regions
Regional analysis underscores divergent growth trajectories and strategic imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, the confluence of robust research funding, advanced diagnostics infrastructure, and progressive regulatory frameworks sustains demand for cutting-edge sample handling solutions. Meanwhile, established pharmaceutical and biotechnology hubs in North America continue to drive adoption of automated workflows and informatics platforms, reinforcing the region’s leadership in innovation.
Across Europe Middle East & Africa, regulatory harmonization efforts and investments in public health initiatives stimulate market expansion, although economic variability among jurisdictions influences procurement cycles. Countries with burgeoning clinical research networks are increasingly prioritizing centralized biorepositories and integrated cold chain logistics. In contrast, Asia-Pacific markets exhibit rapid growth fueled by expanding biopharmaceutical R&D, the proliferation of contract research organizations, and escalating healthcare expenditures. Strategic partnerships between global suppliers and local distributors are amplifying market penetration, while infrastructure upgrades in emerging economies are accelerating adoption of advanced sample preservation and monitoring technologies.
Identifying Leading Companies Driving Innovation, Collaboration, and Competitive Advantage in the Evolving Biological Sample Handling Landscape Worldwide
Competitive analysis reveals a dynamic ecosystem of multinational corporations, specialized instrument developers, and niche reagent manufacturers shaping the future of sample handling. Leading global players are extending their portfolios through strategic collaborations and targeted acquisitions, integrating automated platforms with digital services to deliver end-to-end solutions. At the same time, innovative startups are challenging traditional models by introducing disruptive technologies, such as microfluidic sample prep systems and AI-driven quality assurance software.
Partnerships between instrument suppliers and reagent developers are becoming increasingly prevalent, aiming to offer optimized system compatibility and application-specific protocols. Moreover, the convergence of life science informatics providers with equipment manufacturers is fostering seamless data interoperability and remote monitoring capabilities. As competition intensifies, companies that demonstrate nimble product development, robust customer support, and scalable service models will secure sustainable differentiation in a rapidly evolving market landscape.
Implementing Actionable Strategic Roadmaps for Industry Leaders to Strengthen Resilience, Drive Efficiency, and Accelerate Growth in Sample Handling Operations
To capitalize on emerging opportunities, industry leaders should invest in modular automation platforms that enable rapid scaling and customization for diverse applications. Strengthening supply chain resilience through multipronged sourcing strategies and regional manufacturing partnerships will mitigate the impact of trade disruptions and ensure consistent access to critical materials. Additionally, integrating comprehensive informatics systems with real-time environmental monitoring and predictive analytics will enhance sample integrity and operational efficiency.
Leaders must also prioritize workforce development by equipping laboratory personnel with digital literacy and best practices in cold chain management to reduce error rates and maintain compliance. Collaborating with regulatory bodies to shape guidelines and standardize validation protocols can accelerate market entry for advanced solutions. Finally, embedding sustainability initiatives-such as eco-friendly consumables and carbon-efficient cold storage-will not only address environmental concerns but also resonate with socially conscious stakeholders and funding agencies. By executing these strategic imperatives, organizations can future proof their sample handling operations and drive long-term growth.
Adopting Rigorous Research Methodologies to Ensure Holistic and Accurate Insights into Biological Sample Handling Market Trends and Operational Best Practices
This research integrates primary and secondary methodologies to ensure comprehensive and validated insights. Expert interviews with laboratory directors, procurement managers, and product development leads illuminate real-world challenges and adoption barriers. Concurrently, secondary sources, including industry white papers, regulatory guidelines, and peer-reviewed scientific publications, provide a robust contextual framework.
Quantitative data has been triangulated through cross-referencing proprietary shipment records, financial disclosures, and trade databases to capture market movement patterns. Qualitative assessments are enriched by case studies that illustrate best practices in automation deployment and reagent selection. Analytical modeling techniques, such as scenario planning and sensitivity analysis, underpin forecasts of technology uptake and regional demand. This multidisciplinary approach ensures that the findings reflect both granular operational nuances and macro-level market trends, empowering stakeholders with actionable, data driven insights.
Concluding Strategic Imperatives and Forward Looking Perspectives to Navigate Complexity and Drive Sustainable Growth in Biological Sample Handling Markets
The convergence of advanced automation, digital informatics, and strategic supply chain reconfiguration heralds a new chapter in biological sample handling. Organizations that embrace integrated solutions and cultivate adaptable procurement frameworks will distinguish themselves in an environment defined by cost pressures and regulatory complexity. Equally, a nuanced understanding of regional dynamics and application-specific requirements will enable precise alignment of product offerings and service models.
Looking ahead, the interplay between sustainability objectives, regulatory evolution, and technological innovation will continue to shape competitive advantage. Companies that foster collaborative ecosystems-linking instrument manufacturers, reagent developers, and end users-stand to benefit from shared expertise and co-innovation opportunities. Ultimately, a proactive stance toward transformative shifts in sample integrity, workflow optimization, and data interoperability will drive sustained growth and elevate the quality of healthcare and life science research worldwide.
Market Segmentation & Coverage
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
Product Type
Consumables
Instruments
Automated Pipetting Systems
Temperature Controlled Centrifuges
Vortex Mixers
Reagents And Kits
Antibodies
Buffers And Solutions
Enzymes
Labeling And Detection Reagents
Software And Services
End User
Academic And Research Institutes
Biopharmaceutical Companies
Contract Research Organizations
Diagnostic Laboratories
Clinical Chemistry
Hematology
Microbiology
Molecular Diagnostics
Hospitals
Application
Diagnostics
Laboratory Diagnostics
Point Of Care
Drug Discovery And Development
Genomics
Proteomics
Sample Type
Blood
Cells
Tissue
Urine
Workflow
Analysis
Collection
Processing
Storage
Transport
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
Americas
North America
United States
Canada
Mexico
Latin America
Brazil
Argentina
Chile
Colombia
Peru
Europe, Middle East & Africa
Europe
United Kingdom
Germany
France
Russia
Italy
Spain
Netherlands
Sweden
Poland
Switzerland
Middle East
United Arab Emirates
Saudi Arabia
Qatar
Turkey
Israel
Africa
South Africa
Nigeria
Egypt
Kenya
Asia-Pacific
China
India
Japan
Australia
South Korea
Indonesia
Thailand
Malaysia
Singapore
Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
Thermo Fisher Scientific Inc.
Danaher Corporation
Merck KGaA
Agilent Technologies, Inc.
Avantor, Inc.
Bio-Rad Laboratories, Inc.
PerkinElmer, Inc.
Sartorius AG
QIAGEN N.V.
General Electric Company
Note: PDF & Excel + Online Access - 1 Year
Revolutionizing Sample Integrity Through Strategic Biological Specimen Management to Elevate Research Quality and Patient Outcomes Across Global Markets
Biological sample handling stands at the heart of both clinical diagnostics and groundbreaking research initiatives, where specimen integrity directly influences the accuracy of analytical outcomes. The critical imperative to maintain sample viability from collection through analysis has never been more pronounced, as laboratories contend with increasingly stringent regulatory expectations and the imperative to drive operational efficiency. From academic institutions to diagnostic laboratories, the ability to manage specimens under precise temperature, contamination control, and traceability conditions underpins successful outcomes and fosters trust in results.
As the complexity of life science research expands, stakeholders must navigate a fragmented ecosystem of consumables, instruments, reagents, and software platforms designed to safeguard specimen quality. The demand for seamless integration across each phase of sample workflow has catalyzed a wave of innovation in automated systems, digital monitoring solutions, and advanced reagent formulations. By examining the foundational elements of specimen management, this report sets the stage for an in-depth exploration of technological advancements, regulatory influences, and market dynamics, equipping decision makers with the insights necessary to anticipate emerging challenges and capitalize on transformative opportunities.
Navigating Disruptive Technological and Operational Shifts Driving Next Generation Sample Handling Solutions in Life Sciences and Diagnostics Sectors
The landscape of biological sample handling is undergoing a rapid metamorphosis driven by the convergence of advanced automation, digitalization, and data analytics. Cutting-edge robotic pipetting solutions, integrated with real-time monitoring sensors, are redefining laboratory throughput and reducing human error. Concurrently, the rise of cloud-based laboratory informatics platforms enables seamless data capture, secure traceability, and remote oversight, revolutionizing how teams collaborate across geographic boundaries.
Moreover, the integration of artificial intelligence and machine learning tools is empowering predictive maintenance of critical equipment, early detection of deviations in sample storage conditions, and optimization of workflow processes. These transformative shifts not only enhance operational resilience but also facilitate compliance with evolving regulatory frameworks. In parallel, sustainability imperatives are driving the development of eco-friendly consumables and energy-efficient cold chain solutions. Altogether, this fusion of technological, environmental, and compliance-driven advances signals a new era in sample handling-one defined by precision, connectivity, and agility.
Evaluating the Broad Repercussions of New United States Tariff Regulations in 2025 on the Complex Ecosystem of Biological Sample Handling Supplies and Services
The introduction of revised tariff measures by the United States in 2025 has exerted multifaceted pressure across the biological sample handling supply chain. Elevated duties on imported reagents, consumables, and specialized instruments have prompted procurement teams to reevaluate sourcing strategies and negotiate new partnerships. In response to cost escalations, several stakeholders have pursued localized manufacturing collaborations, thereby mitigating exposure to volatile trade policies and reducing lead times for critical supplies.
Transitioning from traditional global sourcing models, companies are investing in regional distribution hubs and forging alliances with domestic producers to preserve margin integrity and ensure uninterrupted access to essential sample processing materials. Simultaneously, end users have been compelled to recalibrate budgeting forecasts, prioritizing products that deliver heightened durability and extended shelf life to offset incremental expenses. As organizations adapt to this evolving tariff landscape, the emphasis on supply chain transparency, compliance management, and strategic inventory buffering will continue to shape the competitive dynamics of the sample handling market.
Gaining Deep Insights into Product, End User, Application, Sample Type, and Workflow Segmentation to Optimize Biological Sample Handling Strategies
Deep segmentation analysis uncovers unique insights across product categories, end user profiles, application areas, sample types, and workflow stages. Within the spectrum of product types, the market extends from fundamental consumables and sophisticated instruments to specialized reagents and kits and comprehensive software and services. Instruments such as automated pipetting systems, temperature controlled centrifuges, and vortex mixers are gaining momentum, while reagents and kits comprised of antibodies, buffers and solutions, enzymes, and labeling and detection reagents underpin critical assay performance.
Turning to end users, the needs of academic and research institutes, biopharmaceutical companies, contract research organizations, diagnostic laboratories, and hospitals diverge based on throughput requirements and regulatory mandates. Diagnostic laboratories, encompassing clinical chemistry, hematology, microbiology, and molecular diagnostics, remain particularly sensitive to throughput and quality control imperatives. Application segmentation highlights the prominence of diagnostics, drug discovery and development, genomics, and proteomics, with laboratory diagnostics and point of care modalities transforming healthcare delivery.
Sample type considerations reveal distinct protocols for blood, cells, tissue, and urine, each demanding tailored handling and preservation solutions. Furthermore, the sample handling workflow traverses analysis, collection, processing, storage, and transport, where each phase presents specific performance benchmarks. By synthesizing these segmentation dimensions, stakeholders can align product portfolios with evolving user requirements and optimize channel strategies to unlock sustained value.
Uncovering Regional Dynamics Shaping Biological Sample Handling Markets in the Americas, Europe Middle East Africa, and Asia Pacific Regions
Regional analysis underscores divergent growth trajectories and strategic imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, the confluence of robust research funding, advanced diagnostics infrastructure, and progressive regulatory frameworks sustains demand for cutting-edge sample handling solutions. Meanwhile, established pharmaceutical and biotechnology hubs in North America continue to drive adoption of automated workflows and informatics platforms, reinforcing the region’s leadership in innovation.
Across Europe Middle East & Africa, regulatory harmonization efforts and investments in public health initiatives stimulate market expansion, although economic variability among jurisdictions influences procurement cycles. Countries with burgeoning clinical research networks are increasingly prioritizing centralized biorepositories and integrated cold chain logistics. In contrast, Asia-Pacific markets exhibit rapid growth fueled by expanding biopharmaceutical R&D, the proliferation of contract research organizations, and escalating healthcare expenditures. Strategic partnerships between global suppliers and local distributors are amplifying market penetration, while infrastructure upgrades in emerging economies are accelerating adoption of advanced sample preservation and monitoring technologies.
Identifying Leading Companies Driving Innovation, Collaboration, and Competitive Advantage in the Evolving Biological Sample Handling Landscape Worldwide
Competitive analysis reveals a dynamic ecosystem of multinational corporations, specialized instrument developers, and niche reagent manufacturers shaping the future of sample handling. Leading global players are extending their portfolios through strategic collaborations and targeted acquisitions, integrating automated platforms with digital services to deliver end-to-end solutions. At the same time, innovative startups are challenging traditional models by introducing disruptive technologies, such as microfluidic sample prep systems and AI-driven quality assurance software.
Partnerships between instrument suppliers and reagent developers are becoming increasingly prevalent, aiming to offer optimized system compatibility and application-specific protocols. Moreover, the convergence of life science informatics providers with equipment manufacturers is fostering seamless data interoperability and remote monitoring capabilities. As competition intensifies, companies that demonstrate nimble product development, robust customer support, and scalable service models will secure sustainable differentiation in a rapidly evolving market landscape.
Implementing Actionable Strategic Roadmaps for Industry Leaders to Strengthen Resilience, Drive Efficiency, and Accelerate Growth in Sample Handling Operations
To capitalize on emerging opportunities, industry leaders should invest in modular automation platforms that enable rapid scaling and customization for diverse applications. Strengthening supply chain resilience through multipronged sourcing strategies and regional manufacturing partnerships will mitigate the impact of trade disruptions and ensure consistent access to critical materials. Additionally, integrating comprehensive informatics systems with real-time environmental monitoring and predictive analytics will enhance sample integrity and operational efficiency.
Leaders must also prioritize workforce development by equipping laboratory personnel with digital literacy and best practices in cold chain management to reduce error rates and maintain compliance. Collaborating with regulatory bodies to shape guidelines and standardize validation protocols can accelerate market entry for advanced solutions. Finally, embedding sustainability initiatives-such as eco-friendly consumables and carbon-efficient cold storage-will not only address environmental concerns but also resonate with socially conscious stakeholders and funding agencies. By executing these strategic imperatives, organizations can future proof their sample handling operations and drive long-term growth.
Adopting Rigorous Research Methodologies to Ensure Holistic and Accurate Insights into Biological Sample Handling Market Trends and Operational Best Practices
This research integrates primary and secondary methodologies to ensure comprehensive and validated insights. Expert interviews with laboratory directors, procurement managers, and product development leads illuminate real-world challenges and adoption barriers. Concurrently, secondary sources, including industry white papers, regulatory guidelines, and peer-reviewed scientific publications, provide a robust contextual framework.
Quantitative data has been triangulated through cross-referencing proprietary shipment records, financial disclosures, and trade databases to capture market movement patterns. Qualitative assessments are enriched by case studies that illustrate best practices in automation deployment and reagent selection. Analytical modeling techniques, such as scenario planning and sensitivity analysis, underpin forecasts of technology uptake and regional demand. This multidisciplinary approach ensures that the findings reflect both granular operational nuances and macro-level market trends, empowering stakeholders with actionable, data driven insights.
Concluding Strategic Imperatives and Forward Looking Perspectives to Navigate Complexity and Drive Sustainable Growth in Biological Sample Handling Markets
The convergence of advanced automation, digital informatics, and strategic supply chain reconfiguration heralds a new chapter in biological sample handling. Organizations that embrace integrated solutions and cultivate adaptable procurement frameworks will distinguish themselves in an environment defined by cost pressures and regulatory complexity. Equally, a nuanced understanding of regional dynamics and application-specific requirements will enable precise alignment of product offerings and service models.
Looking ahead, the interplay between sustainability objectives, regulatory evolution, and technological innovation will continue to shape competitive advantage. Companies that foster collaborative ecosystems-linking instrument manufacturers, reagent developers, and end users-stand to benefit from shared expertise and co-innovation opportunities. Ultimately, a proactive stance toward transformative shifts in sample integrity, workflow optimization, and data interoperability will drive sustained growth and elevate the quality of healthcare and life science research worldwide.
Market Segmentation & Coverage
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
Product Type
Consumables
Instruments
Automated Pipetting Systems
Temperature Controlled Centrifuges
Vortex Mixers
Reagents And Kits
Antibodies
Buffers And Solutions
Enzymes
Labeling And Detection Reagents
Software And Services
End User
Academic And Research Institutes
Biopharmaceutical Companies
Contract Research Organizations
Diagnostic Laboratories
Clinical Chemistry
Hematology
Microbiology
Molecular Diagnostics
Hospitals
Application
Diagnostics
Laboratory Diagnostics
Point Of Care
Drug Discovery And Development
Genomics
Proteomics
Sample Type
Blood
Cells
Tissue
Urine
Workflow
Analysis
Collection
Processing
Storage
Transport
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
Americas
North America
United States
Canada
Mexico
Latin America
Brazil
Argentina
Chile
Colombia
Peru
Europe, Middle East & Africa
Europe
United Kingdom
Germany
France
Russia
Italy
Spain
Netherlands
Sweden
Poland
Switzerland
Middle East
United Arab Emirates
Saudi Arabia
Qatar
Turkey
Israel
Africa
South Africa
Nigeria
Egypt
Kenya
Asia-Pacific
China
India
Japan
Australia
South Korea
Indonesia
Thailand
Malaysia
Singapore
Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
Thermo Fisher Scientific Inc.
Danaher Corporation
Merck KGaA
Agilent Technologies, Inc.
Avantor, Inc.
Bio-Rad Laboratories, Inc.
PerkinElmer, Inc.
Sartorius AG
QIAGEN N.V.
General Electric Company
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
188 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Adoption of single-use bioprocessing technologies to minimize cross-contamination in biologics manufacturing
- 5.2. Implementation of IoT-enabled cold chain monitoring devices for real-time sample integrity tracking across supply chains
- 5.3. Expansion of decentralized point-of-care testing requiring robust sample stabilization and transport solutions
- 5.4. Development of cryogenic sample preservation methods leveraging novel cryoprotectants to improve long-term viability
- 5.5. Growth of laboratory automation platforms integrating AI-driven quality control for sample handling and data management
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Biological Sample Handling Market, by Product Type
- 8.1. Consumables
- 8.2. Instruments
- 8.2.1. Automated Pipetting Systems
- 8.2.2. Temperature Controlled Centrifuges
- 8.2.3. Vortex Mixers
- 8.3. Reagents And Kits
- 8.3.1. Antibodies
- 8.3.2. Buffers And Solutions
- 8.3.3. Enzymes
- 8.3.4. Labeling And Detection Reagents
- 8.4. Software And Services
- 9. Biological Sample Handling Market, by End User
- 9.1. Academic And Research Institutes
- 9.2. Biopharmaceutical Companies
- 9.3. Contract Research Organizations
- 9.4. Diagnostic Laboratories
- 9.4.1. Clinical Chemistry
- 9.4.2. Hematology
- 9.4.3. Microbiology
- 9.4.4. Molecular Diagnostics
- 9.5. Hospitals
- 10. Biological Sample Handling Market, by Application
- 10.1. Diagnostics
- 10.1.1. Laboratory Diagnostics
- 10.1.2. Point Of Care
- 10.2. Drug Discovery And Development
- 10.3. Genomics
- 10.4. Proteomics
- 11. Biological Sample Handling Market, by Sample Type
- 11.1. Blood
- 11.2. Cells
- 11.3. Tissue
- 11.4. Urine
- 12. Biological Sample Handling Market, by Workflow
- 12.1. Analysis
- 12.2. Collection
- 12.3. Processing
- 12.4. Storage
- 12.5. Transport
- 13. Biological Sample Handling Market, by Region
- 13.1. Americas
- 13.1.1. North America
- 13.1.2. Latin America
- 13.2. Europe, Middle East & Africa
- 13.2.1. Europe
- 13.2.2. Middle East
- 13.2.3. Africa
- 13.3. Asia-Pacific
- 14. Biological Sample Handling Market, by Group
- 14.1. ASEAN
- 14.2. GCC
- 14.3. European Union
- 14.4. BRICS
- 14.5. G7
- 14.6. NATO
- 15. Biological Sample Handling Market, by Country
- 15.1. United States
- 15.2. Canada
- 15.3. Mexico
- 15.4. Brazil
- 15.5. United Kingdom
- 15.6. Germany
- 15.7. France
- 15.8. Russia
- 15.9. Italy
- 15.10. Spain
- 15.11. China
- 15.12. India
- 15.13. Japan
- 15.14. Australia
- 15.15. South Korea
- 16. Competitive Landscape
- 16.1. Market Share Analysis, 2024
- 16.2. FPNV Positioning Matrix, 2024
- 16.3. Competitive Analysis
- 16.3.1. Thermo Fisher Scientific Inc.
- 16.3.2. Danaher Corporation
- 16.3.3. Merck KGaA
- 16.3.4. Agilent Technologies, Inc.
- 16.3.5. Avantor, Inc.
- 16.3.6. Bio-Rad Laboratories, Inc.
- 16.3.7. PerkinElmer, Inc.
- 16.3.8. Sartorius AG
- 16.3.9. QIAGEN N.V.
- 16.3.10. General Electric Company
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
